Show simple item record

dc.creatorSingh, Arvind Rupen
dc.creatorSingh, Jai Rupen
dc.creatorVanita, Vanitaen
dc.date.accessioned2011-07-12T18:21:13Zen
dc.date.available2011-07-12T18:21:13Zen
dc.date.created2008en
dc.date.issued2008en
dc.identifier.bibliographicCitationJournal of Biolaw and Business 2008; 11(2): 45-49en
dc.identifier.urihttp://hdl.handle.net/10822/512193en
dc.formatArticleen
dc.languageengen
dc.source312353en
dc.subjectDiseaseen
dc.subjectIndustryen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationGenetics, Molecular Biology and Microbiologyen
dc.subject.classificationResearch on Foreign Nationalsen
dc.titleThe genetic disease burden in the molecular diagnostic industry in Indiaen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885